377 related articles for article (PubMed ID: 28437788)
21. Type 1 Diabetes and Polycystic Ovary Syndrome: Systematic Review and Meta-analysis.
Escobar-Morreale HF; Roldán-Martín MB
Diabetes Care; 2016 Apr; 39(4):639-48. PubMed ID: 27208367
[TBL] [Abstract][Full Text] [Related]
22. Ovarian hyperandrogenism in adolescents and young women with type I diabetes is primarily related to birth weight and body mass index.
Bizzarri C; Benevento D; Ravà L; Patera IP; Schiaffini R; Ciampalini P; Giannone G; Cappa M
Fertil Steril; 2011 Dec; 96(6):1497-1502.e1. PubMed ID: 21982726
[TBL] [Abstract][Full Text] [Related]
23. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.
Broekmans FJ; Knauff EA; Valkenburg O; Laven JS; Eijkemans MJ; Fauser BC
BJOG; 2006 Oct; 113(10):1210-7. PubMed ID: 16972863
[TBL] [Abstract][Full Text] [Related]
24. To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran.
Rashidi H; Ramezani Tehrani F; Bahri Khomami M; Tohidi M; Azizi F
Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():100-5. PubMed ID: 24411130
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of polycystic ovary syndrome in young women who had idiopathic central precocious puberty.
Franceschi R; Gaudino R; Marcolongo A; Gallo MC; Rossi L; Antoniazzi F; Tatò L
Fertil Steril; 2010 Mar; 93(4):1185-91. PubMed ID: 19135667
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.
Becerra-Fernández A; Pérez-López G; Román MM; Martín-Lazaro JF; Lucio Pérez MJ; Asenjo Araque N; Rodríguez-Molina JM; Berrocal Sertucha MC; Aguilar Vilas MV
Endocrinol Nutr; 2014; 61(7):351-8. PubMed ID: 24680383
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic characteristics and metabolic risk factors of cases with polycystic ovary syndrome during adolescence.
Sıklar Z; Berberoğlu M; Çamtosun E; Kocaay P
J Pediatr Adolesc Gynecol; 2015 Apr; 28(2):78-83. PubMed ID: 25850587
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of the polycystic ovary syndrome in female residents of Chengdu, China.
Zhuang J; Liu Y; Xu L; Liu X; Zhou L; Tang L; Kang D; Guo W; He M; Yang F; Qiu D
Gynecol Obstet Invest; 2014; 77(4):217-23. PubMed ID: 24751759
[TBL] [Abstract][Full Text] [Related]
29. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
[TBL] [Abstract][Full Text] [Related]
30. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka.
Kumarapeli V; Seneviratne Rde A; Wijeyaratne CN; Yapa RM; Dodampahala SH
Am J Epidemiol; 2008 Aug; 168(3):321-8. PubMed ID: 18550559
[TBL] [Abstract][Full Text] [Related]
31. [Polycystic ovary syndrome: is there a rise in the prevalence?].
Carmona-Ruiz IO; Saucedo-de la Llata E; Moraga-Sánchez MR; Romeu-Sarró A
Ginecol Obstet Mex; 2015 Dec; 83(12):750-9. PubMed ID: 27290799
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic features of polycystic ovary syndrome in adolescents (review).
Beltadze K; Barbakadze L
Georgian Med News; 2015 Jan; (238):32-4. PubMed ID: 25693210
[TBL] [Abstract][Full Text] [Related]
33. Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents.
Villarroel C; López P; Merino PM; Iñiguez G; Sir-Petermann T; Codner E
Gynecol Endocrinol; 2015; 31(8):625-9. PubMed ID: 26190534
[TBL] [Abstract][Full Text] [Related]
34. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).
Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group
Hum Reprod; 2004 Jan; 19(1):41-7. PubMed ID: 14688154
[TBL] [Abstract][Full Text] [Related]
35. Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood.
Rosenfield RL; Ehrmann DA; Littlejohn EE
J Clin Endocrinol Metab; 2015 Apr; 100(4):1537-43. PubMed ID: 25675386
[TBL] [Abstract][Full Text] [Related]
36. Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic.
Wijeyaratne CN; Seneviratne Rde A; Dahanayake S; Kumarapeli V; Palipane E; Kuruppu N; Yapa C; Seneviratne Rde A; Balen AH
Hum Reprod; 2011 Jan; 26(1):202-13. PubMed ID: 21098627
[TBL] [Abstract][Full Text] [Related]
37. No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus.
Amato MC; Guarnotta V; Ciresi A; Modica R; Pantò F; Giordano C
J Clin Endocrinol Metab; 2014 Jan; 99(1):203-11. PubMed ID: 24243639
[TBL] [Abstract][Full Text] [Related]
38. What is the Risk of Metabolic Syndrome in Adolescents with Normal BMI who have Polycystic Ovary Syndrome?
Aydin Y; Hassa H; Burkankulu D; Arslantas D; Sayiner D; Ozerdogan N
J Pediatr Adolesc Gynecol; 2015 Aug; 28(4):271-4. PubMed ID: 26049937
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of polycystic ovary syndrome in women with type 2 diabetes in Kerman, Iran.
Mirzaei F; Kazemi N
Metab Syndr Relat Disord; 2008 Sep; 6(3):215-7. PubMed ID: 18710333
[TBL] [Abstract][Full Text] [Related]
40. [Diagnosis of polycystic ovary syndrome].
Belosi C; Giuliani M; Suriano R; Sagnella F; Lanzone A
Minerva Ginecol; 2004 Feb; 56(1):7-13. PubMed ID: 14973406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
